Medical Patent News

RSS

Cubist enters license agreement with Teva to dismiss CUBICIN patent lawsuit

Cubist Pharmaceuticals, Inc. today announced that it has entered into a license agreement with Teva Parenteral Medicines, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd., which includes a stipulation by the parties requesting dismissal of the lawsuit filed by Cubist in the U.S. District Court for the District of Delaware relating to the Abbreviated New Drug Application filed by TPM with the U.S. Food and Drug Administration for a generic version of CUBICIN.

5 Apr 2011

Medical industry veteran set to play key role as Microvisk gears up to launch Smartstrip®

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, today announced that it has strengthened its Board with the appointment of medical industry veteran, Bill Moffitt, as Chairman and Peter Whitehouse as CFO.

4 Apr 2011

USPTO issues patent to Asterand's BioMAP technology

Asterand plc, a leading provider of human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, and its subsidiary BioSeek LLC today announced that the United States Patent and Trademark Office has issued U.S. Patent Nos. 7,908,089 entitled "Patient classification" and 7,912,651 entitled "Function homology screening."

1 Apr 2011

USPTO grants composition-of-matter patent to Zalicus 'Synavive' product

Zalicus Inc. announced today that it has been granted a composition-of-matter patent by the U.S. Patent and Trademark office covering its product candidate Synavive.

30 Mar 2011

USPTO issues patent to Somaxon's Silenor food effect

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 7,915,307, entitled "Methods of Improving the Pharmacokinetics of Doxepin."

30 Mar 2011

USPTO issues Notice of Allowance to Modular's green surfactant patent application

Modular Genetics, Inc. is a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are cost competitive, provide superior performance and are environmentally friendly. Modular's lead product is a "green" surfactant initially targeting the personal care market.

29 Mar 2011

Biotectix acquires Chameleon BioSurfaces technology

Biotectix, LLC announced today the acquisition of all significant assets owned by Chameleon BioSurfaces Ltd. (Cambridge, United Kingdom). Financial terms were not disclosed.

28 Mar 2011

U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit

Watson Pharmaceuticals, Inc., a leading integrated global pharmaceutical company, today confirmed that it has received a favorable decision from the U.S. Court of Appeals for the Federal Circuit related to its ongoing patent challenge in connection with Watson's Abbreviated New Drug Application seeking FDA approval to market a generic version of Teva Women's Health, Inc.'s SEASONIQUE and ethinyl estradiol.

28 Mar 2011

US District Court rules against Watson in generic Fentora patent suit

Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) infringes United States Patent No. 6,264,981 (the '981 Patent). The Company said that it was reviewing the court's decision and would evaluate all available options, including an appeal.

25 Mar 2011

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate

AlphaRx Inc. has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment.

25 Mar 2011

VARI, Gentel Biosciences receive U.S. Patent for new glycan detection technology

Gentel Biosciences, a leader in proteomics tools, and Van Andel Research Institute, a biomedical research institute, jointly announce today the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide. Gentel first obtained an exclusive right to commercialize the technology in 2006.

25 Mar 2011

Colorcon announces specific details on its patent positions for enteric coatings

Colorcon, Inc., a wholly owned subsidiary of BPSI Holdings Inc., today announced specific details on its world-wide patent positions for enteric coating compositions in response to misleading statements made in the international press, particularly in India.

24 Mar 2011

ACT to be awarded broad patent protection in China for hESC-derived RPE cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that China's State Intellectual Property Office (SIPO) has allowed the Company's patent application to provide broad intellectual property protection in China for the manufacturing and pharmaceutical preparations of retinal pigment epithelial (RPE) cells from human embryonic stem cells (hESCs).

24 Mar 2011

NephRx receives new U.S. patent for NX002 to treat IBD

NephRx Corporation today announced issuance of a new U.S. patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease.

24 Mar 2011

USPTO grants patent to ULURU's Altrazeal product

ULURU Inc. announced today that it has been issued U.S. Patent 7,910,135 – Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses.

24 Mar 2011

NephRx receives new U.S. patent for NX002 to treat oral mucositis

NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.

23 Mar 2011

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

23 Mar 2011

POZEN files motion for Treximet patent litigation against Par

POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that it has filed a motion for a preliminary injunction seeking to prevent Par Pharmaceuticals, Inc. from launching a generic version of Treximet.

23 Mar 2011

BDSI's BEMA drug delivery technology receives Canada patent

BioDelivery Sciences International, Inc. announced the issuance of a patent extending the exclusivity of the BioErodible MucoAdhesive drug delivery technology in Canada from 2017 to 2027. The patent was been reviewed by the Office of Patented Medicines for listing in the Canadian Patent Register and was found eligible for listing.

22 Mar 2011

USPTO grants patent to HistoRx methods for digital microscopy standardization

HistoRx, Inc., announced today that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for standardization of digital microscopy instruments in order to go beyond imaging to generating high-quality reproducible data that precisely relates to biomarker concentrations in tissue sections.

22 Mar 2011

Medical Patent News

Cubist enters license agreement with Teva to dismiss CUBICIN patent lawsuit

Medical industry veteran set to play key role as Microvisk gears up to launch Smartstrip®

USPTO issues patent to Asterand's BioMAP technology

USPTO grants composition-of-matter patent to Zalicus 'Synavive' product

USPTO issues patent to Somaxon's Silenor food effect

USPTO issues Notice of Allowance to Modular's green surfactant patent application

Biotectix acquires Chameleon BioSurfaces technology

U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit

US District Court rules against Watson in generic Fentora patent suit

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate

VARI, Gentel Biosciences receive U.S. Patent for new glycan detection technology

Colorcon announces specific details on its patent positions for enteric coatings

ACT to be awarded broad patent protection in China for hESC-derived RPE cells

NephRx receives new U.S. patent for NX002 to treat IBD

USPTO grants patent to ULURU's Altrazeal product

NephRx receives new U.S. patent for NX002 to treat oral mucositis

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

POZEN files motion for Treximet patent litigation against Par

BDSI's BEMA drug delivery technology receives Canada patent

USPTO grants patent to HistoRx methods for digital microscopy standardization

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News